These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 241845

  • 1. Gel entrapped L-asparaginase: kinetic behavior and antitumor activity.
    O'Driscoll KF, Korus RA, Ohnuma T, Walczack IM.
    J Pharmacol Exp Ther; 1975 Nov; 195(2):382-8. PubMed ID: 241845
    [Abstract] [Full Text] [Related]

  • 2. Acrylic microspheres in vivo. II. The effect in rat of L-asparaginase given in microparticles of polyacrylamide.
    Edman P, Sjöholm I.
    J Pharmacol Exp Ther; 1979 Dec; 211(3):663-7. PubMed ID: 512928
    [Abstract] [Full Text] [Related]

  • 3. An isocratic fluorescence HPLC assay for the monitoring of l-asparaginase activity and l-asparagine depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia.
    Nath CE, Dallapozza L, Eslick AE, Misra A, Carr D, Earl JW.
    Biomed Chromatogr; 2009 Feb; 23(2):152-9. PubMed ID: 18823071
    [Abstract] [Full Text] [Related]

  • 4. Use of immobilized L-asparaginase in acrylic microparticles in an extracorporeal hollow-fiber dialyzer.
    Edman P, Nylén U, Sjöholm I.
    J Pharmacol Exp Ther; 1983 Apr; 225(1):164-7. PubMed ID: 6834269
    [Abstract] [Full Text] [Related]

  • 5. Increased antitumor activity of Escherichia coli. L-asparaginase by modification with monomethoxypolyethylene glycol.
    Kamisaki Y, Wada H, Yagura T, Nishimura H, Matsushima A, Inada Y.
    Gan; 1982 Jun; 73(3):470-4. PubMed ID: 6751921
    [Abstract] [Full Text] [Related]

  • 6. Reduction in immunogenicity and clearance rate of Escherichia coli L-asparaginase by modification with monomethoxypolyethylene glycol.
    Kamisaki Y, Wada H, Yagura T, Matsushima A, Inada Y.
    J Pharmacol Exp Ther; 1981 Feb; 216(2):410-4. PubMed ID: 7007618
    [Abstract] [Full Text] [Related]

  • 7. [Immobilization of Citrobacter L-asparaginase in polyacrylamide gel].
    Galaev IuV, Chuplygina EG, Klement'eva TA.
    Vopr Med Khim; 1981 Feb; 27(4):534-7. PubMed ID: 7293086
    [Abstract] [Full Text] [Related]

  • 8. L-Asparagine depletion levels and L-asparaginase activity in plasma of children with acute lymphoblastic leukemia under asparaginase treatment.
    Tsurusawa M, Chin M, Iwai A, Nomura K, Maeba H, Taga T, Higa T, Kuno T, Hori T, Muto A, Yamagata M, Japanese Children's Cancer and Leukemia Study Group.
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):204-8. PubMed ID: 14634792
    [Abstract] [Full Text] [Related]

  • 9. Acrylic microspheres in vivo VI: antitumor effect of microparticles with immobilized L-asparaginase against 6C3HED lymphoma.
    Edman P, Sjöholm I.
    J Pharm Sci; 1983 Jun; 72(6):654-8. PubMed ID: 6875826
    [Abstract] [Full Text] [Related]

  • 10. Synthesis, characterization and immunogenicity of silk fibroin-L-asparaginase bioconjugates.
    Zhang YQ, Zhou WL, Shen WD, Chen YH, Zha XM, Shirai K, Kiguchi K.
    J Biotechnol; 2005 Nov 21; 120(3):315-26. PubMed ID: 16102867
    [Abstract] [Full Text] [Related]

  • 11. The chemical modification of E. coli L-asparaginase by N,O-carboxymethyl chitosan.
    Qian G, Zhou J, Ma J, Wang D, He B.
    Artif Cells Blood Substit Immobil Biotechnol; 1996 Nov 21; 24(6):567-77. PubMed ID: 8922226
    [Abstract] [Full Text] [Related]

  • 12. Basis for loss of therapeutic effectiveness of L-asparaginase in sensitized mice.
    Baechtel S, Prager MD.
    Cancer Res; 1973 Aug 21; 33(8):1966-9. PubMed ID: 4578567
    [No Abstract] [Full Text] [Related]

  • 13. L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans.
    Riccardi R, Holcenberg JS, Glaubiger DL, Wood JH, Poplack DG.
    Cancer Res; 1981 Nov 21; 41(11 Pt 1):4554-8. PubMed ID: 6895481
    [Abstract] [Full Text] [Related]

  • 14. [Results of an experimental study of the antitumor activity of 1-asparaginase from E. coli and Erw. carotovora].
    Terent'eva TG, Sokolov AB, Navashin SM.
    Antibiotiki; 1977 Jan 21; 22(1):78-81. PubMed ID: 320935
    [Abstract] [Full Text] [Related]

  • 15. Pharmacology of Escherichia coli-L-asparaginase polyethylene glycol adduct.
    Park YK, Abuchowski A, Davis S, Davis F.
    Anticancer Res; 1981 Jan 21; 1(6):373-6. PubMed ID: 7046623
    [Abstract] [Full Text] [Related]

  • 16. A Dacron wool packed-bed extracorporeal reactor: a kinetic study of immobilized Escherichia coli II L-asparaginase.
    KO RY, Hersh LS.
    J Biomed Mater Res; 1976 Mar 21; 10(2):249-58. PubMed ID: 3508
    [Abstract] [Full Text] [Related]

  • 17. [Immobilized asparaginase and its use in medicine].
    Kozlov EA, Petriĭ OP.
    Vopr Med Khim; 1978 Mar 21; 24(6):723-33. PubMed ID: 32657
    [No Abstract] [Full Text] [Related]

  • 18. Advantages in the use of L-asparaginase-albumin polymer as an antitumor agent.
    Poznansky MJ, Shandling M, Salkie MA, Elliott JF, Lau E.
    Cancer Res; 1982 Mar 21; 42(3):1020-5. PubMed ID: 6895861
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic properties of a new glutaminase-asparaginase preparation and the influence of the lactate dehydrogenase-elevating virus.
    Riley V, Spackman D, Fitzmaurice MA, Roberts J, Holcenberg JS, Dolowy WC.
    Cancer Res; 1974 Feb 21; 34(2):429-38. PubMed ID: 4810909
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of polyethylene glycol-modified L-asparaginase from Escherichia coli and its application to therapy of leukemia.
    Yoshimoto T, Nishimura H, Saito Y, Sakurai K, Kamisaki Y, Wada H, Sako M, Tsujino G, Inada Y.
    Jpn J Cancer Res; 1986 Dec 21; 77(12):1264-70. PubMed ID: 3102431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.